Revlimib and metastases to kidney Patient Reports February 09, 2012

Revlimib Side Effects Report #5368521-5
Revlimib side effect was reported by a Health Professional from UNITED STATES on June 12, 2007. Female patient, 71 years of age, was diagnosed with multiple myeloma  and was treated with Revlimib. After drug was administered, patient experienced the following side effects: metastases to kidney. Revlimib dosage: 15 MG, X 21 DAYS, ORAL. Patient recovered.